
Closed
Last Update: April 29, 2026
Funding available
$ 300,000
Timeline
- Closing date : June 1, 2023
Location
Alberta, Canada
Overview
This program supports research on cannabis-based medicines and tools to address pain and knowledge gaps in medical cannabis use. Eligible projects may receive up to $300,000 for a maximum term of 24 months.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Conduct research and development activities
- Conduct research or evaluation activities
Eligible Funding
- Maximum amount : 300,000 $
Timeline
- Closing date : June 1, 2023
Eligible candidates
Eligible Industries
- Professional, scientific and technical services
- Educational services
- Health care and social assistance
- Public administration
Location
- Alberta
Legal structures
- All legal structures
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Pre-clinical research on cannabis phytochemicals for pain or analgesic properties.
- Mechanistic studies using model systems or organisms other than humans.
- Analytical and computational research, including AI or machine learning approaches.
- Post-market data-focused ideas to improve patient outcomes and support the cannabis industry.
Documents Needed
- Application form
- Supporting information
- Non-confidential graphical abstract
Eligibility
Who is eligible?
- Alberta-based post-secondary institutions.
- Government entities or health delivery agents.
- Eligible not-for-profit organizations with a presence in Alberta.
Who is not eligible
- Organizations that are not Alberta-based or do not have a legal and physical presence in Alberta, where required.
- Applicants that do not meet the program's organization-type requirements.
Eligible expenses
- Salaries and benefits for staff, students, or contractors working directly on the project.
- Equipment, materials, supplies, and necessary software licenses.
- Specialized equipment or services directly related to the project.
- Travel and accommodation for field work or project dissemination, within program limits.
- Other costs pre-approved in writing, including project-specific patent filing costs.
Ineligible Costs and Activities
- Costs incurred before the Investment Agreement is signed.
- Costs above market price.
- General administration and indirect overhead costs.
- Costs for human clinical trials.
- Expenses outside the project scope or term, or not directly tied to deliverables and milestones.
Eligible geographic areas
- Alberta
Processing and Agreement
- Applications are reviewed by internal staff and external expert reviewers.
- Projects are assessed for scientific and technical merit, innovation opportunity, impact potential, and project design.
- Alberta Innovates makes the funding decision at its sole discretion.
- Successful applicants must sign an Investment Agreement before funding starts.
- Progress and performance reporting are part of ongoing project management.
Additional information
- Alberta Innovates may modify the program guide from time to time.
- Only the authorized contact named in the application will receive written correspondence.
- The program includes a Request for Information stream intended to inform a future call.
- Applications and agreements are subject to Alberta Innovates' sole discretion.
Contacts
Frequently Asked Questions about the mCannabis Program
Here are answers to the most common questions about the mCannabis. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the mCannabis?
This program supports research on cannabis-based medicines and tools to address pain and knowledge gaps in medical cannabis use. Eligible projects may receive up to $300,000 for a maximum term of 24 months.
How much funding can be received?
mCannabis Funds up to $300,000 of admissible expenses.
Who is eligible for the mCannabis program?
To be eligible for the mCannabis program, you must:
Alberta-based eligible organization.
Project meets program milestones and term.
Required cannabis licensing or exemptions, if needed.
What expenses are eligible under mCannabis?
Pre-clinical research on cannabis phytochemicals for pain or analgesic properties.
Mechanistic studies using model systems or organisms other than humans.
Analytical and computational research, including AI or machine learning approaches.
Post-market data-focused ideas to improve patient outcomes and support the cannabis industry.
Who can I contact for more information about the mCannabis?
You can contact Alberta Innovates by email at Sunil.Rajput@albertainnovates.ca or by phone at 780-603-3905.
Where is the mCannabis available?
The mCannabis program is available the province of Alberta.
Is the mCannabis a grant, loan, or tax credit?
mCannabis is a Researchers And Facilities